Today's Information

Provided by: TaiMed Biologics Inc.
SEQ_NO 3 Date of announcement 2022/05/30 Time of announcement 15:53:15
Subject 
 Announcement of members of the Company's
Compensation Committee
Date of events 2022/05/30 To which item it meets paragraph 6
Statement 
1.Date of occurrence of the change:2022/05/30
2.Name of the functional committees:Compensation Committee
3.Name of the previous position holder:
 (1) Ming-Ching Chen
 (2) Howard S. Lee
 (3) Peter Kurz
4.Resume of the previous position holder:
 (1) Ming-Ching Chen/Professorof of Accounting, National ChengChi University
 (2) Howard S. Lee/Chairman of TAHO Pharmceuticals and Transwell Biotech Co.
 (3) Peter Kurz/former managing director and head of the research department
     of the Taipei branch of Citigroup
5.Name of the new position holder:
 (1) Chin-Ting, Chiu
 (2) Howard S. Lee
 (3) Gwo-Fong Lin
6.Resume of the new position holder:
 (1) Chin-Ting, Chiu/former chairman, Securities and Futures Investors
     Protection Center
 (2) Howard S. Lee/Chairman of TAHO Pharmceuticals and Transwell Biotech Co.
 (3) Gwo-Fong Lin/Distinguished Professor, National Taiwan University
7.Circumstances of change (Please enter "resignation", "dismissal",
"term expired", "death" or "new appointment"):term expired
8.Reason for the change:term expired and re-election
9.Original term (from __________ to __________):2019/06/06 to 2022/06/05
10.Effective date of the new member:2022/05/30
11.Any other matters that need to be specified:None

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

TaiMed Biologics Inc. published this content on 30 May 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 30 May 2022 14:38:07 UTC.